Sensitivity analyses by removing the study with the largest sample
| MACE/MACCE | Death | MI | Revascularisation | Death or MI | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I2 (95% CI) | Results | p Value | I2 (95% CI) | Results | p Value | I2 (95% CI) | Results | p Value | I2 (95% CI) | Results | p Value | I2 (95% CI) | Results | p Value | |
| Removing a study with the largest sample size | |||||||||||||||
| Li, 2013 | 57% (0% to 84%) | 1.90 (1.26 to 2.87) | 0.002 | – | – | – | 59% (0% to 86%) | 3.57 (1.30 to 9.75) | 0.01 | 39% (0% to 77%) | 1.58 (1.21 to 2.06) | <0.001 | 0% (0% to 85%) | 1.91 (1.41 to 2.59) | <0.001 |
| Frohlich, 2014 | – | – | – | 0% (0% to 88%) | 1.64 (1.37 to 1.96) | <0.001 | – | – | – | – | – | – | – | – | |
MACE, major adverse cardiac events; MACCE, major adverse cardiac and cerebrovascular events; MI, myocardial infarction; RR, relative risk; RD, risk difference.